Evidence map›Paper›PMID 40964057›Full record

ArticleFrontiers in cellular and infection microbiology2025

Microbiota composition and intestinal barrier function modulated by tamsulosin and

Silvia Valeria Padilla-García, Abraham Loera-Muro, Martín Humberto Muñoz-Ortega, David Alejandro Hernández-Marín, Javier Ventura-Juárez, Sandra Luz Martínez-Hernández

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Frontiers in microbiology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Silvia Valeria Padilla-GarcíaDepartment of Morphology, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Ags, Mexico.
Abraham Loera-MuroSecihti-Center for Biological Research of the Northwest, SC, La Paz, Mexico.
Martín Humberto Muñoz-OrtegaDepartment of Chemistry, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Ags, Mexico.
David Alejandro Hernández-MarínDepartment of Microbiology, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Ags, Mexico.
Javier Ventura-JuárezDepartment of Morphology, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Ags, Mexico.
Sandra Luz Martínez-HernándezDepartment of Microbiology, Center for Basic Sciences, Autonomous University of Aguascalientes, Aguascalientes, Ags, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The pathological progression of cirrhosis disrupts the gut-liver axis. Material and methods: Male Wistar rats were administered CCl Results: Conclusión: Findings such as reduced bacterial translocation, lower systemic endotoxin levels, improved intestinal morphology, and modulation of gut microbiota composition suggest that both agents (

Indexed as

Gastrointestinal MicrobiomeIntestinal MucosaLactococcus lactisLiver CirrhosisProbioticsTamsulosinAnimalsBacteriaBacterial TranslocationDisease Models, AnimalIntestinal Barrier FunctionLiverMaleOccludinRatsRats, WistarOccludinRNA, Ribosomal, 16STamsulosinZonula Occludens-1 Proteinbacterial translocationcirrhosisintestinal permeabilityL. lactismicrobiotatamsulosin

Identifiers

PMID40964057
PMCPMC12436309

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.